A beta hCG test is a blood test that measures human chorionic gonadotropin, a hormone produced during pregnancy. It can detect pregnancy as early as seven to 10 days after conception, before a missed period and earlier than any home urine test. Beyond pregnancy, the test also serves as a marker for certain cancers and pregnancy complications.
Why It’s Called “Beta” hCG
Human chorionic gonadotropin is made up of two parts: an alpha subunit and a beta subunit. The alpha subunit is shared by several other hormones in your body, including those involved in thyroid function and reproductive signaling. The beta subunit, however, is unique to hCG. That’s what makes it useful as a test target. By measuring the beta subunit specifically, the test avoids confusion with those other hormones and gives a reliable signal that hCG is present.
Qualitative vs. Quantitative Tests
There are two versions of the blood test, and they answer different questions.
A qualitative test simply tells you whether hCG is present: yes or no. It confirms pregnancy but doesn’t tell you anything about how the pregnancy is progressing.
A quantitative test measures the exact amount of hCG in your blood, reported in mIU/mL. This version is more informative. Doctors use it to estimate how far along a pregnancy is, monitor whether hCG is rising at a healthy rate, or track hCG levels after treatment for certain medical conditions. When people refer to a “beta hCG test,” they usually mean the quantitative version.
How hCG Levels Change in Early Pregnancy
Once a fertilized egg implants in the uterus, typically six to 10 days after conception, the placental cells begin producing hCG. Levels rise rapidly during the first trimester, roughly doubling every two to three days in a healthy pregnancy, before plateauing and then declining. Here’s what typical ranges look like by week (measured from the last menstrual period):
- Week 3: 5 to 50 mIU/mL
- Week 4: 5 to 426 mIU/mL
- Week 5: 18 to 7,340 mIU/mL
- Week 6: 1,080 to 56,500 mIU/mL
- Weeks 7 to 8: 7,650 to 229,000 mIU/mL
- Weeks 9 to 12: 25,700 to 288,000 mIU/mL
These ranges are wide because normal hCG levels vary enormously between individuals. A single reading matters less than the trend over multiple tests. If your doctor orders serial beta hCG tests a few days apart, they’re looking at whether the number is climbing at the expected pace rather than comparing your level to a chart.
Blood Test vs. Home Urine Test
Home pregnancy tests also detect hCG, but they rely on urine, where the hormone appears in lower concentrations and later than in blood. A blood beta hCG test can pick up pregnancy seven to 10 days after conception, while most home tests aren’t reliable until around the time of a missed period, roughly 14 days after conception.
Blood tests are also more precise. Home tests give a yes-or-no answer at a fixed sensitivity threshold, and semi-quantitative urine tests have been shown to miss about 11% of cases where blood hCG was above 1,000 IU/L. For straightforward pregnancy confirmation, a home test is usually enough. Blood tests become valuable when early detection matters, when levels need to be tracked over time, or when results are ambiguous.
What the Test Involves
The beta hCG blood test is a simple blood draw from a vein in your arm. No fasting, no special preparation, no timing requirements. Results from a quantitative test typically come back within a few hours to a day, depending on the lab.
When Doctors Order the Test
Pregnancy confirmation is the most common reason for a beta hCG test, but it has several other uses.
In early pregnancy, serial quantitative tests help evaluate whether a pregnancy is developing normally. Levels that plateau or rise too slowly can signal an ectopic pregnancy (where the embryo implants outside the uterus) or an impending miscarriage. Unusually high levels for the gestational age can point to a molar pregnancy, a condition where abnormal placental tissue grows instead of a normal embryo. In complete molar pregnancies, hCG values can be markedly elevated.
Beta hCG is also part of first-trimester screening for Down syndrome, where it’s combined with other blood markers and an ultrasound measurement to estimate risk.
Outside of pregnancy, beta hCG acts as a tumor marker. It plays a key role in managing gestational trophoblastic disease, testicular cancer, and ovarian germ cell tumors. In these cases, rising hCG signals active disease while falling levels after treatment indicate a good response. Some non-reproductive cancers can also produce hCG, though this is less common.
What Abnormal Results Can Mean
Higher-than-expected hCG levels during pregnancy may indicate a molar pregnancy, multiple pregnancies (twins or more), or a miscalculated due date. Lower-than-expected levels, or levels that fail to double appropriately, may suggest ectopic pregnancy, miscarriage, or a pregnancy that’s simply earlier than estimated.
Outside pregnancy, elevated hCG can come from several sources. Women in menopause normally produce small amounts of hCG from the pituitary gland, which can occasionally trigger a positive result. Certain fertility medications, including injectable hCG products like Ovidrel, Pregnyl, and Novarel, will also cause elevated readings. If you’re taking any of these, the timing of your test matters: residual medication can linger in your system and produce a false positive.
Rarely, substances in the blood called heterophile antibodies can interfere with the assay and produce a falsely elevated result. If a positive result doesn’t match the clinical picture, doctors may rerun the test using a different assay method to rule out this kind of interference.
Tracking hCG After Pregnancy Loss or Treatment
After a miscarriage, ectopic pregnancy treatment, or evacuation of a molar pregnancy, doctors often monitor beta hCG levels until they return to zero. This confirms that no residual tissue remains that could continue producing the hormone. For molar pregnancies in particular, persistent or rising hCG after treatment can indicate invasive disease or, in rare cases, choriocarcinoma, a fast-growing cancer that responds well to treatment when caught early. Monitoring schedules vary, but they can continue for weeks to months depending on the situation.